Surmodics Profit Margin

The latest profit margin for SRDX is -14.59% as of June 2025. That compares with -1.16% in the prior-year period — down 1160.2% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Surmodics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SRDX's profit margin moved from -1.16% to -14.59% — a 1160.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Surmodics's valuation or profitability profile.

Against Healthcare companies, SRDX currently prints -14.59% for profit margin, while the sector average sits near 15.29%. That is roughly 195.4% below the sector mean. Large gaps often invite a closer look at Surmodics's growth, margins, and balance sheet.

Profit Margin shows how effectively Surmodics converts resources into returns. At -14.59%, SRDX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1.16% in the prior-year period — down 1160.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SRDX's profit margin (-14.59%), review year-over-year change from -1.16%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.